a favorable trendP =0.02
In addition, the patients with WT KRAS with a favorable trend (n=11) showed a median PFS of 14.7 months, higher than that of the patients with WT KRAS with unfavorable kinetics (n=9), of 9.4 months ( P =0.02; Figure 6 ).
In addition, the patients with WT KRAS with a favorable trend (n=11) showed a median PFS of 14.7 months, higher than that of the patients with WT KRAS with unfavorable kinetics (n=9), of 9.4 months ( P =0.02; Figure 6 ).